Grade 3 Dermatitis Secondary to Two Aromatase Inhibitors in Early Hormone Receptor-Positive Breast Cancer: A Case

Katherine Gayford1, Nicola O'Neill1, Ahmed Hadeya1

  • 1Oncology, University College Hospital, London, GBR.

Cureus
|November 28, 2025
PubMed
Summary

A rare, severe skin reaction occurred in a patient treated with two aromatase inhibitors (AIs) for breast cancer. The patient tolerated a third AI, highlighting the need for research into managing these rare adverse events.